Amalgamated Bank’s 2seventy bio TSVT Stock Holding History

Amalgamated Bank’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,763	Closed	-$9K	–	3146
2025 Q1	$9K	Hold	1,763	–	–	﹤0.01%	2445
2024 Q4	$5K	Hold	1,763	–	–	﹤0.01%	2760
2024 Q3	$8K	Hold	1,763	–	–	﹤0.01%	2581
2024 Q2	$7K	Buy	1,763 +465	+36%	+$2.1K	﹤0.01%	2646
2024 Q1	$7K	Sell	1,298 -2,688	-67%	-$12.6K	﹤0.01%	2611
2023 Q4	$17K	Sell	3,986 -386	-9%	-$1.19K	﹤0.01%	2730
2023 Q3	$17K	Hold	4,372	–	–	﹤0.01%	2737
2023 Q2	$44K	Buy	4,372 +503	+13%	+$5.33K	﹤0.01%	2379
2023 Q1	$39K	Sell	3,869 -865	-18%	-$9.89K	﹤0.01%	2409
2022 Q4	$44K	Hold	4,734	–	–	﹤0.01%	2484
2022 Q3	$69K	Hold	4,734	–	–	﹤0.01%	2323
2022 Q2	$62K	Buy	4,734 +2,012	+74%	+$27.4K	﹤0.01%	2377
2022 Q1	$46K	Buy	+2,722	New	+$46.2K	﹤0.01%	2527

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Amalgamated Bank's TSVT Position: Q2 2025 in Review

Amalgamated Bank sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 1,763 shares — an estimated $9K sold.

Amalgamated Bank first reported a position in TSVT in Q1 2022 and held it in 13 quarters. The position peaked at $69K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Amalgamated Bank reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 1,763 2seventy bio shares in Q2 2025, an estimated $9K.
Amalgamated Bank first reported a position in 2seventy bio in Q1 2022 and held it in 13 quarters.
Amalgamated Bank's 2seventy bio position peaked at $69K in Q3 2022.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.